2013 annual financial data
Celldex Therapeutics 2013 Operating margin
Direct answer
Operating margin was -1,981.08%.
Operating income was -81,442,000 USD and net income was -81,550,000 USD.
Operating cash flow was -67,669,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,111,000 USD
- Operating income
- -81,442,000 USD
- Net income
- -81,550,000 USD
- Operating cash flow
- -67,669,000 USD